Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.31 and traded as low as $0.28. Northwest Biotherapeutics shares last traded at $0.29, with a volume of 2,079,674 shares trading hands.
Northwest Biotherapeutics Price Performance
The stock has a market capitalization of $383.51 million, a P/E ratio of -3.59 and a beta of -0.50. The company’s 50 day simple moving average is $0.27 and its two-hundred day simple moving average is $0.31.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($0.02) earnings per share for the quarter. The company had revenue of $0.36 million during the quarter.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Featured Articles
- Five stocks we like better than Northwest Biotherapeutics
- What Are Growth Stocks and Investing in Them
- Oracle Announces Game-Changing News for the AI Industry
- Best Stocks Under $10.00
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Consumer Staples Stocks, Explained
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
